In India in 2021, an estimated 504,000 people died from tuberculosis, or TB. That's almost one per minute. More than a quarter of the estimated TB cases worldwide are in India.
May 4, 2022
0
24
The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is one of the world's oldest and most widely used vaccines, used to immunize 100 million newborns every year. Given in countries with endemic TB, ...
May 3, 2022
0
185
Briefly blocking a key molecule when administering the only approved vaccine for tuberculosis vastly improves long-term protection against the devastating disease in mice, researchers from Texas Biomedical Research Institute ...
Mar 11, 2022
0
45
Researchers at Massachusetts General Hospital (MGH), in partnership with NYU Langone Health, have launched a multi-center clinical trial to investigate a new treatment for pediatric type 1 diabetes even in subjects with established ...
Mar 1, 2022
0
5
A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it's still given to infants today. For generations, the vaccine has saved lives and prevented untold suffering. And yet TB still kills ...
Dec 13, 2021
0
225
The COVID-19 pandemic has turned a spotlight on the importance of vaccines, but also on key gaps in scientific understanding of how the immune system reacts to vaccines in general. Why does the immune response to some vaccines ...
Dec 3, 2021
0
122
Being vaccinated during childhood with the BCG (Bacille Calmette-Guérin) vaccine against tuberculosis is not a long-term protective factor against COVID-19, despite what was thought at the beginning of the pandemic. A team ...
Oct 25, 2021
0
1
A century-old tuberculosis vaccine could help reduce the incidence of eczema in high-risk infants due to its beneficial off-target effects, according to a new MCRI-led allergy study.
Aug 24, 2021
0
156
By some estimates, 2 billion people are now infected worldwide, and in 2019, around 1.4 million people died from it.
Aug 9, 2021
0
6
A team of researchers from the CMR-National Institute for Research in Tuberculosis and the ICMR-National Institute of Epidemiology, both in India, has found evidence suggesting that an old vaccine used to reduce the threat ...
